𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-acting risperidone improves negative symptoms in stable psychotic patients

✍ Scribed by V.A. Curtis; K. Katsafouros; H.J. Moeller; R. Medori; E. Sacchetti


Book ID
118438290
Publisher
Elsevier Science
Year
2007
Tongue
French
Weight
45 KB
Volume
22
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term safety and efficacy of long-ac
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (β‰₯65 years) with psychosis stabilized on oral or depot a